Zurich Cantonal Bank’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,393
| Closed | -$63.2K | – | 2728 |
|
|
2023
Q3 | $63.2K | Buy |
3,393
+2,320
| +216% | +$48.1K | ﹤0.01% | 2533 |
|
|
2023
Q2 | $27.9K | Hold |
1,073
| – | – | ﹤0.01% | 2694 |
|
|
2023
Q1 | $30.8K | Hold |
1,073
| – | – | ﹤0.01% | 2696 |
|
|
2022
Q4 | $31.8K | Hold |
1,073
| – | – | ﹤0.01% | 2698 |
|
|
2022
Q3 | $26K | Hold |
1,073
| – | – | ﹤0.01% | 2749 |
|
|
2022
Q2 | $24K | Hold |
1,073
| – | – | ﹤0.01% | 2769 |
|
|
2022
Q1 | $27K | Hold |
1,073
| – | – | ﹤0.01% | 2629 |
|
|
2021
Q4 | $38K | Hold |
1,073
| – | – | ﹤0.01% | 2793 |
|
|
2021
Q3 | $46K | Hold |
1,073
| – | – | ﹤0.01% | 2636 |
|
|
2021
Q2 | $46K | Hold |
1,073
| – | – | ﹤0.01% | 2468 |
|
|
2021
Q1 | $44K | Hold |
1,073
| – | – | ﹤0.01% | 2422 |
|
|
2020
Q4 | $49K | Sell |
1,073
-866
| -45% | -$32.9K | ﹤0.01% | 2438 |
|
|
2020
Q3 | $69K | Hold |
1,939
| – | – | ﹤0.01% | 2146 |
|
|
2020
Q2 | $73K | Buy |
1,939
+982
| +103% | +$32.4K | ﹤0.01% | 2085 |
|
|
2020
Q1 | $28K | Hold |
957
| – | – | ﹤0.01% | 2215 |
|
|
2019
Q4 | $50K | Hold |
957
| – | – | ﹤0.01% | 2142 |
|
|
2019
Q3 | $53K | Hold |
957
| – | – | ﹤0.01% | 1992 |
|
|
2019
Q2 | $39K | Hold |
957
| – | – | ﹤0.01% | 2206 |
|
|
2019
Q1 | $29K | Hold |
957
| – | – | ﹤0.01% | 2282 |
|
|
2018
Q4 | $32K | Hold |
957
| – | – | ﹤0.01% | 2266 |
|
|
2018
Q3 | $40K | Hold |
957
| – | – | ﹤0.01% | 2262 |
|
|
2018
Q2 | $31K | Hold |
957
| – | – | ﹤0.01% | 2328 |
|
|
2018
Q1 | $48K | Hold |
957
| – | – | ﹤0.01% | 2094 |
|
|
2017
Q4 | $52K | Buy |
957
+383
| +67% | +$21.2K | ﹤0.01% | 2037 |
|
|
2017
Q3 | $33K | Hold |
574
| – | – | ﹤0.01% | 2044 |
|
|
2017
Q2 | $28K | Hold |
574
| – | – | ﹤0.01% | 2106 |
|
|
2017
Q1 | $25K | Hold |
574
| – | – | ﹤0.01% | 2210 |
|
|
2016
Q4 | $28K | Hold |
574
| – | – | ﹤0.01% | 2119 |
|
|
2016
Q3 | $27K | Buy |
574
+126
| +28% | +$6.22K | ﹤0.01% | 2087 |
|
|
2016
Q2 | $24K | Hold |
448
| – | – | ﹤0.01% | 1950 |
|
|
2016
Q1 | $20K | Hold |
448
| – | – | ﹤0.01% | 2042 |
|
|
2015
Q4 | $17K | Buy |
448
+252
| +129% | +$9.64K | ﹤0.01% | 2173 |
|
|
2015
Q3 | $6K | Hold |
196
| – | – | ﹤0.01% | 2346 |
|
|
2015
Q2 | $6K | Hold |
196
| – | – | ﹤0.01% | 1716 |
|
|
2015
Q1 | $8K | Buy |
+196
| New | +$7.92K | ﹤0.01% | 1489 |
|
Other funds holding ANIK
TI
CP
BFM
CM
Zurich Cantonal Bank's ANIK Position: Q4 2023 in Review
Zurich Cantonal Bank sold out of Anika Therapeutics (ANIK) in Q4 2023, closing a stake of 3,393 shares — an estimated $63.2K sold.
Zurich Cantonal Bank first reported a position in ANIK in Q1 2015 and held it in 35 quarters. The position peaked at $73K in Q2 2020. 117 funds tracked by Wall St. Rank hold ANIK as of Q4 2023.
- Zurich Cantonal Bank reported no remaining Anika Therapeutics position as of Q4 2023 after selling out during the quarter.
- Zurich Cantonal Bank sold 3,393 Anika Therapeutics shares in Q4 2023, an estimated $63.2K.
- Zurich Cantonal Bank first reported a position in Anika Therapeutics in Q1 2015 and held it in 35 quarters.
- Zurich Cantonal Bank's Anika Therapeutics position peaked at $73K in Q2 2020.
- 117 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2023.
Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.